Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Tranexamic acid: The patients who meet the inclusion criteria will be included in the study and will receive
Inj.Tranexamic acid first dose (1gm IV in 100ml Normal Saline) initially at
Sponsors
Dr Medagani Bhargav
Eligibility
Inclusion criteria
Inclusion criteria: Patients giving informed consent. Female patients with operable breast cancer undergoing modified radical mastectomy of age more than 18 year.
Exclusion criteria
Exclusion criteria: • Advanced breast cancer patients in which upfront surgery is not indicated. • Known thrombotic disease or high risk of thromboembolism. • Patients on anticoagulants. • Denial of consent. • Pregnant females. • Patients deemed unfit for surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the effect of tranexamic acid and botropase in reduction of postoperative bleeding and seroma formation in post Modified radical Mastectomy patientsTimepoint: 1 week | — |
Secondary
| Measure | Time frame |
|---|---|
| To reduce Postoperative wound healing time. Postoperative hospital stay. Postoperative surgical site infections.Timepoint: 2 weeks | — |
Countries
India
Contacts
Public ContactDr Pankaj Kumar Verma
Government Medical College, Haldwani
Outcome results
None listed